REFERENCES
- Peach M. J. Renin-angiotensin system: Biochemistry and mechanisms of action. Physiol Rev. 1977; 57: 313–370
- The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med. 1997; 157: 2413–46
- Dzau V. J., Mukoyama M., Pratt R. E. Molecular biology of angiotensin receptors: target for drug research?. J Hypertens Suppl. 1994; 12: S1–5
- Inagami T. Molecular biology and signaling of angiotensin receptors: an overview. J Am Soc Nephrol. 1999; 10(Suppl 11)S2–7
- Dzau V. J., Sasamura H., Hein L. Heterogeneity of angiotensin synthetic pathways and receptor subtypes: physiological and pharmacologic implications. J Hypertens. 1993; 11(suppl. 3)S13–S18
- Horiuchi M., Akishita M., Dzau V. J. Recent progress in angiotensin II type 2 receptor research in the cardiovascular system. Hypertension. 1999; 33: 613–21
- Matsubara H. Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases. Circ Res. 1998; 83: 1182–91
- Arima S., Endo Y., Yaoita H., Omata K., Ogawa S., Tsunoda K., Abe M., Takeuchi K., Abe K., Ito S. Possible role of P-450 metabolite of arachidonic acid in vasodilator mechanism of angiotensin II type 2 receptor in the isolated microperfused rabbit afferent arteriole. J Clin Invest. 1997; 100: 2816–23
- Siragy H. M., Inagami T., Ichiki T., Carey R. M. Sustained hypersensitivity to angiotensin II and its mechanism in mice lacking the subtype-2 (AT2) angiotensin receptor. Proc Natl Acad Sci U S A. 1999; 96: 6506–10
- Tsutsumi Y., Matsubara H., Masaki H., Kurihara H., Murasawa S., Takai S., Miyazaki M., Nozawa Y., Ozono R., Nakagawa K., Miwa T., Kawada N., Mori Y., Shibasaki Y., Tanaka Y., Fujiyama S., Koyama Y., Fujiyama A., Takahashi H., Iwasaka T. Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation. J Clin Invest. 1999; 104: 925–935
- Carey R. M., Wang Z. Q., Siragy H. M. Role of the angiotensin type 2 receptor in the regulation of blood pressure and renal function. Hypertension. 2000; 35: 155–63
- Gigante B., Piras O., De Paolis P., Porcellini A., Natale A., Volpe M. Role of the angiotensin II AT2-subtype receptors in the blood pressure-lowering effect of losartan in salt-restricted rats. J Hypertens. 1998; 16: 2039–43
- Anderson P. W., Do Y. S., Hsueh W. A. Angiotensin II causes mesangial cell hypertrophy. Hypertension. 1993; 21: 29–35
- Goto M., Mukoyama M., Suga S., Matsumoto T., Nakagawa M., Ishibashi R., Kasahara M., Sugawara A., Tanaka I., Nakao K. Growth-dependent induction of angiotensin II type 2 receptor in rat mesangial cells. Hypertension. 1997; 30: 358–62
- Paxton W. G., Runge M., Horaist C., Cohen C., Alexander R. W., Bernstein K. E. Immunohistochemical localization of rat angiotensin II AT1 receptor. Am J Physiol. 1993; 264: F989–95
- Harrison-Bernard L. M., Navar L. G., Ho M. M., Vinson G. P., el-Dahr S. S. Immunohistochemical localization of ANG II AT1 receptor in adult rat kidney using a monoclonal antibody. Am J Physiol. 1997; 273: F170–7
- Miyata N., Park F., Li X. F., Cowley A. W., Jr. Distribution of angiotensin AT1 and AT2 receptor subtypes in the rat kidney. Am J Physiol. 1999; 277: F437–46
- Ozono R., Wang Z., Moore A. F., Inagami T., Siragy H. M., Carey R. M. Expression of the subtype 2 angiotensin (AT2) receptor protein in rat kidney. Hypertension. 1997; 30: 1238–1246
- Matsubara H., Sugaya T., Murasawa S., Nozawa Y., Mori Y., Masaki H., Maruyama K., Tsutumi Y., Shibasaki Y., Moriguchi Y., Tanaka Y., Iwasaka T., Inada M. Tissue-specific expression of human angiotensin II AT1 and AT2 receptors and cellular localization of subtype mRNAs in adult human renal cortex in situ hybridization. Nephron. 1998; 80: 25–34
- Sasamura H., Nakazato Y., Hayashida T., Kitamura Y., Hayashi M., Saruta T. Regulation of vascular type 1 angiotensin receptors by cytokines. Hypertension. 1997; 30: 35–41
- Horiuchi M., Hayashida W., Akishita M., Yamada S., Lehtonen J. Y., Tamura K., Daviet L., Chen Y. E., Hamai M., Cui T. X., Iwai M., Minokoshi Y. Interferon-gamma induces AT(2) receptor expression in fibroblasts by Jak/STAT pathway and interferon regulatory factor-1. Circ Res. 2000; 86: 233–40
- Okada H., Konishi K., Nakazato Y., Kanno Y., Suzuki H., Sakaguchi H., Saruta T. Interleukin-4 expression in mesangial proliferative glomerulonephritis. Am J Kidney Dis. 1994; 23: 242–6